$1365.09
76.795.96%
Last update: Oct 29, 1:32 PM
Eli Lilly and Co
LLYNYSE
Eli Lilly (LLY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Eli Lilly (LLY) last issued guidance on October 29, 2026 for fiscal year 2026. The company guided earnings per share in the range of $35 - $36, compared to a consensus EPS estimate of $34.21. Eli Lilly also guided revenue in the range of $91B - $92B for the period.
Compared to prior guidance, Eli Lilly lowered its EPS outlook from a previous range of $35.5 - $36.5. On the revenue side, the company raised its revenue forecast from a prior range of $85B - $87B.
Eli Lilly has issued 23 guidance updates between November 1, 2022 and October 29, 2026. During this period, the company raised its outlook 12 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.36 | $6.01 | $6.85 | $6.96 |
| Actual | $7.48 | $8.38 | $8.55 | $7.54 |
| Surprise | +17.6% | +39.4% | +24.8% | +8.33% |
| Revenue | ||||
| Estimate | $22.51B | $20.44B | $17.78B | $17.91B |
| Actual | $24.40B | $22.97B | $19.80B | $19.30B |
| Surprise | +8.36% | +12.4% | +11.4% | +7.74% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $10.23 | $9.70 | $10.40 |
| Revenue | |||
| Consensus | $23.70B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $7.48 | $6.36 | 17.6 % |
| Q2 | Aug 5, 2026 | $8.38 | $6.01 | 39.4 % |
| Q1 | Apr 30, 2026 | $8.55 | $6.85 | 24.8 % |
| Q4 | Feb 4, 2026 | $7.54 | $6.96 | 8.33 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $24.40B | $22.51B | 8.36 % |
| Q2 | Aug 5, 2026 | $22.97B | $20.44B | 12.4 % |
| Q1 | Apr 30, 2026 | $19.80B | $17.78B | 11.4 % |
| Q4 | Feb 4, 2026 | $19.30B | $17.91B | 7.74 % |
